TY - JOUR
AU1 - Nightingale, Stuart L.
AB - and Administration From the Food Drug HIV Western Blot Kit The ferent donor drawn at least six antibacterial for Approved: samples broad-spectrum agent, FDA use a months In of adults with has licensed for commercial to treatment tract addition, provide urinary apart. Western is in vitro indirect evidence ofthe of infections caused blot kit that an strains nonspecificity by susceptible and the reactive an of and for the detection ELISA assay repeatably test, gram-positive gram-negative qualitative human from virus in a aerobic identification of antibodies to manufactured Pseudomo- produced bacteria, including from virus infection cell line different that of the nas It is marketed as immunodeficiency (HIV) aeruginosa. contained in serum or must be Noroxin & human reactive nega¬ Merck plasma. assay by Sharp Dohme, repeatably The used in a tive on the and the West Pa. The a fluoro- both initial new kit, previously only sample Point, drug, research is To determine a is the first intended for use obtained setting, freshly sample. quinolone, second-genera¬ blood as a test on donor's true a tion antibacterial in the with donors frozen follow-up status, agent antibody quinolone found to be reac¬ of the reactive class to be for specimens drug 
TI - From the Food and Drug Administration
JF - JAMA
DO - 10.1001/jama.1987.03390220024007
DA - 1987-06-12
UR - https://www.deepdyve.com/lp/american-medical-association/from-the-food-and-drug-administration-WzOieFVFHC
SP - 3030
EP - 3030
VL - 257
IS - 22
DP - DeepDyve
ER -